article from the hfsa conf., page-4

Hazardous, thank you for posting this.

In a nut-shell, to me, this news is very encouraging. The key elements for me are;
1) 1 patient died = 96.42% survival rate – this is much better than Oz trails (was 83%), but again this is early days yet.
2) Serious adverse effect in 7 patients = 85% non-serious adverse effects
3) Discharge from hospital = 21 patient left hospital within 30 days = 75% NOT 66.7 as published – unless I missed something??!!

There seems to be a cross-over or unclear as to the number of patients discharged and those suffering Adverse Effect (possibly after discharge).

I am not sure what is meant by “patient had expired, while the surviving patients are still on support.”. Support could mean anything, from being on medication to being monitored? Any thoughts??

As I said, for my money, it seems very encouraging.

Cheers